Transcranial magnetic stimulation or TMS is a new treatment that applies rapid magnetic pulses to the brain. The stimulation produces electrical current in the prefrontal cortex of the brain. The FDA has approved TMS (NeuroStar) for the treatment of major depression in those who have not responded to oral antidepressants.
- Treatments are delivered in the office setting while you sit in a special chair.
- Treatments last for about 40 minutes and are done daily for 4 to 6 weeks.
- Patients are awake through the process and there is no need for anesthesia.
- Clinical studies of TMS show that it is effective in roughly 1 out of 4 who receive treatment.
- Side effects are mild and include:
- Scalp irritation
- Mild headaches
Continue to Depression Home Care
- Badamgarav E, Weingarten SR, Henning JM, Knight K, Hasselblad V, Gano A Jr, Ofman JJ. Effectiveness of disease management programs in depression: a systematic review. Am J Psychiatry. 2003 Dec;160(12):2080-90. 
- Bair MJ, Robinson RL, Katon W, Kroenke K. Depression and pain comorbidity: a literature review. Arch Intern Med. 2003 Nov 10;163(20):2433-45. 
- Barrett B, Byford S, Knapp M. Evidence of cost-effective treatments for depression: a systematic review. J Affect Disord. 2005 Jan;84(1):1-13. 
- Neumeyer-Gromen A, Lampert T, Stark K, Kallischnigg G. Disease management programs for depression: a systematic review and meta-analysis of randomized controlled trials. Med Care. 2004 Dec;42(12):1211-21. 
- Remick RA. Diagnosis and management of depression in primary care: a clinical update and review. CMAJ. 2002 Nov 26;167(11):1253-60. 
- Wulsin LR. Is depression a major risk factor for coronary disease? A systematic review of the epidemiologic evidence. Harv Rev Psychiatry. 2004 Mar-Apr;12(2):79-93.